Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04519853 · ClinicalTrials.gov registry record · NA

A Pilot Study of a Low Glycemic Load Diet in Adults With Cystic Fibrosis

A NA study of Cystic Fibrosis and Cystic Fibrosis-related Diabetes, sponsored by Boston Children's Hospital.

Completed
Registry status
NA
Development phase
11
Enrollment target
1
Study location

NCT04519853 is a NA study of Cystic Fibrosis and Cystic Fibrosis-related Diabetes that has completed, run by Boston Children's Hospital. The registered enrollment target is 11 participants, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04519853, a NA study of Cystic Fibrosis and Cystic Fibrosis-related Diabetes, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

This pilot study will evaluate the safety and tolerability of a low glycemic load dietary intervention in adult patients with cystic fibrosis (CF) in a rigorous feeding study. Specific emphasis will be placed on changes in weight, body composition, and glycemic measures obtained via continuous glucose monitor (CGM) usage.

Interventions

  • BEHAVIORAL Low Glycemic Load Diet

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2021-10-25
Est. Completion 2023-07-01
Phase NA

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT04519853

The ClinicalTrials.gov registry entry for NCT04519853 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (94% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cystic Fibrosis appearing as the primary indexed condition, and to 1 intervention - of which Low Glycemic Load Diet is the first listed.

NCT04519853 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04519853 about?

NCT04519853 is a clinical study titled "A Pilot Study of a Low Glycemic Load Diet in Adults With Cystic Fibrosis". This pilot study will evaluate the safety and tolerability of a low glycemic load dietary intervention in adult patients with cystic fibrosis (CF) in a rigorous feeding study. Specific emphasis will be placed on changes in weight, body composition, and glycemic measures obtained via continuous gluco...

What is the current status of trial NCT04519853?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2021-10-25. Estimated completion is 2023-07-01.

What conditions does trial NCT04519853 study?

This clinical trial studies the following conditions: Cystic Fibrosis, Cystic Fibrosis-related Diabetes, Cystic Fibrosis With Intestinal Manifestations.

What interventions are being tested in trial NCT04519853?

The interventions under investigation include: Low Glycemic Load Diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT04519853?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04519853 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cystic Fibrosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.